Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory L. Shiferman currently holds 50,000 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory L. Shiferman has been a net neutral trader of SAGE stock. They have purchased $0 and sold $0 worth of shares.
Gregory L. Shiferman's most recent insider trade was on Apr 1, 2026, when they sold 50,000 shares at $0.00 per share.
Gregory L. Shiferman serves as Executive at Sage Therapeutics, Inc. (SAGE). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Gregory L. Shiferman holds the position of Executive at Sage Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Gregory L. Shiferman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory L. Shiferman was on Apr 1, 2026, when they purchased $0 worth of VYGR shares. This transaction involved 50,000 shares at N/A per share.
Gregory L. Shiferman currently owns 50,000 shares of Sage Therapeutics, Inc. (SAGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory L. Shiferman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory L. Shiferman has 5 Form 4 filings on record as an insider at Sage Therapeutics, Inc..
Set alerts for Gregory L. Shiferman and 40,000+ other insiders.